BioNexus Gene Lab Corp (BGLC) — Cash & Equivalents
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $2.49M | -13.9% |
| 2024 | $2.89M | — |
| 2021 | $2.12M | -23.8% |
| 2020 | $2.79M | +224.5% |
| 2019 | $859.1K | -31.8% |
| 2018 | $1.26M | — |
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $2.49M | -13.9% |
| 2024 | $2.89M | — |
| 2021 | $2.12M | -23.8% |
| 2020 | $2.79M | +224.5% |
| 2019 | $859.1K | -31.8% |
| 2018 | $1.26M | — |